Speakers

Edward Abrahams, Ph.D. Executive Director, Personalized Medicine Coalition Joanne C. Armstrong, M.D. Senior Medical Director for Women's Health and Clinical Lead for Genomics, Aetna, Inc. Samuel J. Aronson Executive Director of Information Technology, Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Mara G. Aspinall Senior Advisor, Genzyme Corporation, Dana-Farber Cancer Institute Linda Avey Co-Founder, 23andMe M. Kathleen Behrens, Ph.D. General Partner, RS Investments, Member, President's Council of Advisors on Science and Technology (PCAST) Richard M.J. Bohmer, MBChB, MPH MBA Class of 1973 Senior Lecturer of Business Administration, Harvard Business School Mary Del Brady President and CEO, RedPath Integrated Pathology, Inc. David J. Brailer, M.D., Ph.D. Chairman, Health Evolution Partners David D. Chang, M.D., Ph.D. Vice President Global Development, Oncology Therapeutics Amgen Inc. George Church, Ph.D. Professor of Genetics, Harvard Medical School, Director, Center for Computational Genetics Clayton M. Christensen, D.B.A Robert and Jane Cizik Professor of Business Administration, Harvard Business School Nadine Cohen, Ph.D. Head of Pharmacogenomics and Senior Research Fellow, Johnson & Johnson Pharmaceutical Research and Development East Coast and Europe Jorge Conde Co-Founder and Chief Executive officer, Knome, Inc. Mark A. Creager, M.D. Professor of Medicine, Brigham and Women's Hospital, Harvard Medical School Neil de Crescenzo Senior Vice President and General Manager, Healthcare and Life Sciences, Oracle Corporation Arthur A. Daemmrich, Ph.D. Assistant Professor of Business Administration, Harvard Business School Janet Dillione Chief Executive Officer, Health Services, Siemens Medical Solutions Gregory Downing, D.O., Ph.D. Program Director, Personalized Health Care, U.S. Department of Health and Human Services Deborah Dunsire, M.D. President and CEO, Millennium: The TAKEDA Oncology Company Robert Epstein, M.D., M.S. Senior Vice President, Medical & Analytical Affairs, and Chief Medical Officer, Medco Health Solutions, Inc Mason W. Freeman, M.D. Chief, Lipid Metabolism Unit, Massachusetts General Hospital, Harvard Medical School Felix W. Frueh, Ph.D. Vice President, R&D Personalized Medicine, Medco Health Solutions John P. Glaser, Ph.D. Vice President and Chief Information Officer, Partners HealthCare Harry Glorikian Managing Partner, Scientia Advisors Sandra Glucksmann, Ph.D. Senior Vice President, Tempo Pharmaceuticals Matthew P. Goetz, M.D. Assistant Professor of Oncology, Assistant Professor of Pharmacology, Mayo Clinic Richard G. Hamermesh, D.B.A. MBA Class of 1961 Professor of Management Practice, Harvard Business School James Heywood Chairman and Co-Founder, PatientsLikeMe Diane Keogh Corporate Director, Research Computing, Partners HealthCare David P. King President and Chief Executive Officer, Laboratory Corporation of America Raju Kucherlapati, Ph.D. Scientific Director, Harvard Medical School-Partners HealthCare Center for Genetics and Genomics, Paul C. Cabot Professor of Genetics, Professor of Medicine, Harvard Medical School The Hon. Michael O. Leavitt Secretary of Health and Human Services, U.S. Department of Health and Human Services Frederick Lee, M.D., MPH Product Manager for Personalized Medicine and Genomics, McKesson Corp. Lawrence J. Lesko, Ph.D., FCP Director, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration Carol J. McCall, FSA, MAAA Vice President, Research and Development, Humana, Inc. Jeffrey D. Miller Vice President, WW Health and Life Sciences, WW Public Sector, Hewlett-Packard Company Thomas J. Miller Chief Executive Officer, Workflow and Solutions, Siemens Healthcare James J. Mongan, M.D. President and Chief Executive Officer, Partners HealthCare Samuel R. Nussbaum, M.D. Executive Vice President and Chief Medical Officer, Wellpoint, Inc. The Lord Naren Patel, MB, ChB House of Lords, United Kingdom Michael Paul, Ph.D. President and CEO, LineaGen Margaret Piper, Ph.D., M.P.H. Director, Genomics Resources, BCBSA Technology Evaluation Center Aidan C. Power, MB BCh MSc MRCPsych Vice President & Global Head of Molecular Medicine, Pfizer Global Research and Development Eiry Roberts, MB (Hons) BS MRCP FFPM Vice President, Transitional Phase Development, Eli Lilly and Company Mollie Roth, Esq. Corporate Counsel, Vice President, Business Development, Diaceutics Christine Seidman, M.D. Investigator, Howard Hughes Medical Institute, Thomas W. Smith Professor of Medicine and Genetics, Harvard Medical School, Director, Cardiovascular Genetics Center, Brigham and Women’s Hospital Dietrich Stephan, Ph.D. Co-founder and Chief Science Officer, Navigenics Steven St. Peter, M.D., M.B.A. Managing Director, MPM Capital Robert I. Tepper, M.D. Partner, Third Rock Ventures, LLC Peter G. Traber, M.D. President and CEO, Baylor College of Medicine Scott Weiss, M.D., M.S. Interim Director, Partners Center for Personalized Genetic Medicine, Director, Center for Genomic Medicine, Associate Director, Channing Laboratory, Professor of Medicine, Harvard Medical School Robert C. Wells Partner, HealthFutures, LLC